NovaBridge Biosciences (NBP) Other Non-Current Assets (2018 - 2025)

NovaBridge Biosciences (NBP) has 8 years of Other Non-Current Assets data on file, last reported at $2.8 million in Q4 2025.

• Quarterly Other Non-Current Assets rose 106.01% year-over-year to $2.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.8 million (up 106.01% YoY) and the FY2025 annual result came in at $2.8 million, up 106.01% from the prior year.
• Other Non-Current Assets advanced to $2.8 million in Q4 2025 per NBP's latest filing, from $1.1 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $4.2 billion in Q4 2021 and bottomed at $464000.0 in Q2 2024.
• The 5-year median for Other Non-Current Assets is $1.3 million (2025), against an average of $321.8 million.
• The widest annual swing landed in 2021, when Other Non-Current Assets jumped 1373416.16%; it then sank 99.92% in 2022.
• Tracing NBP's Other Non-Current Assets over 5 years: stood at $4.2 billion in 2021, then plunged by 99.92% to $3.5 million in 2022, then sank by 83.08% to $594715.8 in 2023, then soared by 129.52% to $1.4 million in 2024, then soared by 106.01% to $2.8 million in 2025.
• Per Business Quant, the three latest NBP Other Non-Current Assets figures stand at $2.8 million (Q4 2025), $1.1 million (Q3 2025), and $1.2 million (Q2 2025).

Peer Comparison